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Abstract: The effect of  selenium (Se) on natural killer (NK) and lymphokine-activated killer (LAK) cell activities and proliferative 
responses of  human lymphocytes was studied in vitro. Direct addition of Se at 1.0 #g/ml final concentration to the mixture of target and 
effector cells during a 4 h cytotoxicity assay significantly suppressed the NK activity of  normal lymphocytes. When lymphocytes were 
preincubated with Se at concentrations as low as 0.2 #g/ml for a period of  48 h, a significant inhibitory effect on NK activity was observed. 
In the LAK cell assay, direct addition of  Se at concentrations of  0.2 1.0 t~g/ml to a mixture of target and effector cells did not show any 
effects on LAK cell activity, whereas LAK cells generated in the presence of Se at 0.8 #g/ml showed significant inhibition of  their 
functions. Lymphocyte proliferative responses to T cell mitogens such as phytohemagglutinin (PHA) and concanavalin A (Con A) were 
also significantly suppressed by direct addition of Se at 0.5 1.0 l~g/ml. The inhibitory effect of Se was not due to nonspecific toxicity of 
effector cells as demonstrated by viability nor was the effect directed against target cells. These studies suggest that although Se is an 
essential micronutrient for various immune mechanisms, an excess of Se may have a deleterious effect on certain immunological func- 
tions. As these activities are considered to be important defense mechanisms against tumors and virus infections, a nutritional imbalance 
of  Se could result in an increased risk of  these disorders. 
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Introduction 
Nutrition plays an important role in host responses 
to various infections and carcinogens (Yang et al., 
1987; Reddy et al., 1980; Byers et al., 1984). Several 
studies have indicated that immunodeficiency or de- 
fective immunoregulation, such as reduced natural 
killer (NK) and lymphokine-activated killer (LAK) 
cells, increased suppressor or decreased helper cell 
activities, or altered T and B cell responses, is asso- 
ciated with cancer (Herberman et al., 1978; Rosen- 
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berg et al., 1986; Whong-Peng et al., 1978). Like 
zinc (Zn) and copper (Cu), selenium (Se) is an ac- 
cepted micronutrient with established RDAs 
(Mertz et al., 1986). Previous studies have shown 
that Se deficiency resulted in down-regulation of 
various immune functions such as lymphocyte pro- 
liferative response to various mitogens (Eskew et 
al., 1985; Parnharn et al., 1983; Sheffy et al., 1979), 
polyclonal B cell activation (Chandra et al., 1982) 
and granulocyte (Urban et al., 1986) and cytotoxic 
cell (Kiremidjian-Schumacher et al., 1987; Petrie et 
al., 1989a) activities, and supplementation of Se was 
associated with restoration of certain depressed im- 
mune functions (Petrie et al., 1989b; Arvilommi et 
al., 1983; Spallholz et al., 1981; Koller et al., 1986). 
A recent study suggests that Se can effectively inhib- 
it mixed lymphocyte culture reactions and in vitro 
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lymphocyte responses to tetanus toxoid (Petrie et 
al., 1986). The effect of Se imbalance on immune 
functions has not been extensively examined, espe- 
cially its effects on the cytotoxic activities of  N K  
and LAK cells. The present study examines the ef- 
fects of  Se (as sodium selenite) on NK, LAK and 
lymphocyte proliferative responses. 
Materials and Methods 
Media 
'Complete medium'  consisted of RPMI  1640 (GIB- 
CO, Grand Island, NY), with 25 mM HEPES buf- 
fer, 80 /~g/ml gentamicin (Schering Corp., Kenil- 
worth, N J), 300 #g of fresh glutamine/ml, and 10% 
heat-inactivated fetal calf serum (v/v). 
Isolation of lymphocytes 
Peripheral blood mononuclear  cells (PBMC) were 
isolated from heparinized (20 U/ml) venous blood 
from healthy normal donors using a modified meth- 
od of Boyum (Boyum, 1968). Blood was diluted 
with an equal volume of normal saline and centri- 
fuged at 400 × g for 30 rain at 18°C. The mononu-  
clear cell band was harvested, washed three times 
with saline, and resuspended in complete medium 
as described (Nair et al., 1988). 
Depletion of adherent cells 
PBMC were suspended in complete medium and 
depleted of adherent cells by passage through a 7 ml 
column of Sephadex G-10 beads (Pharmacia Fine 
Chemicals, Piscataway, N J) and equilibrated in 
complete medium as previously described (Nair et 
al., 1988). After 45 min of incubation at 37°C, non- 
adherent peripheral blood lymphocytes (PBL) were 
eluted with 1 bed volume of medium at 37°C. Cell 
recovery was > 70% of the total input, and mono- 
cyte contamination, as indicated by nonspecific es- 
terase staining, was < 2%. 
Assays Jor NK and LAK cell activities 
LAK and N K  cell activities were determined in a 
direct SlCr-release assay as described previously 
(Nair et al., 1981, 1988). The human myeloid cell 
line, K562, was used as target for N K  cells because 
it is highly susceptible to N K  activity (West et al., 
1977). For the LAK cell assay we chose as target a 
human B cell leukemia line, SB, because of its resist- 
ance to NK activity in a 4 h assay (Korea et al., 
1978). Briefly, varying concentrations of  viable ef- 
fector cells in complete medium were added to trip- 
licate cultures of SlCr-labeled target cells in 0.2 ml 
volumes in V-bottom microtitration plates (Dyna- 
tech Labs, Alexandria, VA). After centrifugation at 
40 x g for 2 min, the cells were incubated at 37°C in 
a humidified atmosphere of  5% CO2 in air for 4 h. 
Percent cytotoxicity was calculated as follows: 
% Cytotoxicity = 
experimental release - spontaneous release 
× 100 
total release spontaneous release 
where total release represents counts obtained in an 
aliquot of 2 x 10 ¢ lysed target cells, and spontane- 
ous release represents counts obtained from control 
wells containing only 2 × 10 ~ target cells and media 
during 4 h incubation. The spontaneous release 
from target cells was always less than 5% of the 
total release. 
Generation o[" LAK cells 
Commercially available recombinant IL2 alpha 
(Collaborative Research, Inc., Bedford, MA) was 
diluted in complete medium and stored at - 70°C  
before use. IL2 concentrations of  5 10 U/ml in 
complete medium were used to generate LAK cells. 
PBL were activated to generate LAK cells by in- 
cubation for 4 days in LAK medium containing Se 
at concentrations ranging from 0.01 to 1 /,g/ml in 
upright 25 c m  2 flasks at a density of  l x 1 0  6 cells/ 
ml at 37°C in a 5% CO2/95% air atmosphere as 
described (Nair et al., 1988). 
LymphocTte prol(/bration assay 
This assay was performed as described (Nair et al., 
1988). Briefly, 2 x 105 PBMC were cultured in 
complete medium containing 10% fetal calf serum 
in sterile U-bot tom microtitration plates (Dyna- 
tech, Alexandria, VA). Specific cultures received Se 
at concentrations of  0.2-1 /~g/ml. Lymphocyte acti- 
vators such as PHA (2.5, 5 and 10/zg/ml) and Con 
A (1, 2.5 and 5 yg/ml) were added to Se-containing 
cultures and incubated for 72 h at 37°C in a 5% 
CO2/air incubator. Control  cultures containing var- 
ying concentrations of  Se or PHA alone were exam- 
ined concomitantly. One ttCi of  [3H]thymidine (1 Ci 
= 37 GBq) was added to each well during the last 
24 h of  incubation. The cultures were collected by 
an automated cell harvester and incorporation of 
[3H]thymidine into lymphocyte D N A  was deter- 
mined with a Beckman Model LS700 scintillation 
counter. Results are expressed as cpm per 2 x 10 s 
cells. 
Statistical analysis 
The significance of differences between control and 
experimental values was determined by a paired 
Student's ' t '  test. 
R e s u l t s  
Effect of selenium ol7 NK and LAK cell activities of 
lymphocytes 
Data  presented in Table I demonstrate the viability 
of  lymphocytes cultured in various concentrations 
of Se for 48 and 96 h respectively for N K  and LAK 
cells as measured by the trypan blue dye exclusion 
technique. Lymphocytes cultured in complete medi- 
um for 48 h with 1 /zg/ml of  Se were 92% viable. 
Lymphocytes cultured in IL2-containing medium 
TABLE l 
Effect of  selenium on NK activity of  lymphocytes 
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Fig. 1. Effect of  Se on NK activity. Se was added directly to the 
reaction mixture of  effector and target cells (K562) and NK ac- 
tivity was measured as described. Results are expressed as mean 
% cytotoxicity J_ SDM of a single experiment performed in 
triplicate. Three other experiments produced similar results. The 
variation ofcytotoxicity produced in the 4 different experiments 
using 4 different lymphocyte samples was in the range 5 to 15% 
at 25:1 effector-to-target (E:T) cell ratios. Similar levels of  var- 
iations occurred with other E:T cell ratios. However, in all exper- 
iments, Se at a concentration of  I ~tg/ml produced significant 
suppression compared to control lymphocytes analysed by 
paired 't" test. 
to generate LAK cells demonstrated 100% viability 
at the end of 96 h of  culture. Se at all tested concen- 
trations produced levels of  viability similar to those 
of  control cultures. This demonstrates that Se at a 
concentration of  up to 1 /g /ml  is not toxic to the 
cells. 
Fig. 1 shows the effect of  Se on N K  activity when 
added directly to the target-effector cell mixture. 
Cytotoxicity was dependent upon the number of  el- 
Source of  Selenium concentrations (ltg/ml) 
effector cells 
0 1 0.5 0.2 0.1 
NK 95.4 :t_ 3.0 92.0 ± 4.0 90.5 ± 2.0 89.6 ± 7.0 98.7 ± 5.7 
(p < 0.4) (p < 0.25) (p < 0.25) (p < 0.4) 
LAK 98.2 ± 4.0 93.3 ± 7.0 90.6 ± 3.2 91.7 ± 5.0 100.0 + 2.1 
(p < 0.4) (p < 0.1) (p < 0.1) (p < 0.4) 
Data are presented as percent viability. 
1 x 106 PBL depleted of adherent cells were cultured for 48 to 96 h in medium containing varying concentrations of Se and tested for 
their viability by the trypan blue dye exclusion assay. The concentration of  Se in the control medium varied from 0.001 to 0.005 ig/ml .  
The data presented are means  ± SD of  4 experiments performed in triplicate. The statistical signiticances were calculated by paired 't '  
test. 
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lector cells used, and the inhibitory effect of  Se oc- 
curred at all effector-to-target (E:T) cell ratios. Se at 
lower concentrations (0.5 and 0.8 #g/ml) did not 
produce significant inhibitory effects on NK activ- 
ity; however, significant suppression of N K  activity 
was observed at 1/~g/ml (p < 0.005, p < 0.02 and p 
< 0.02 respectively at 25:1, 10:1 and 5:1 E:T cell 
ratios). 
The data in Fig. 2 demonstrate the effect of pre- 
culture of lymphocytes  with Se for 48 h on their N K  
activity. A prior kinetic analysis (data not present- 
ed) showed that a minimum incubation period of 48 
h was necessary for Se to effect significant inhibition 
of N K  activity against K562 target cells. Se at 0.2 
/~g/ml produced significant suppression of N K  ac- 
tivity at all E:T cell ratios examined with resultant 
cytotoxicities of  65% (p < 0.01), 46% (p < 0.002) 
and 20% (p < 0.003) at E:T ratios of  50:1, 25:1 and 
10:1 respectively; p values are relative to differences 
between control cultures without added Se. This in- 
hibition was more pronounced at higher Se concen- 
trations. For example, Se at 0.5 #g/ml produced 
41% (p < 0.0), 24% (p < 0.001) and 8% (p < 
0.001) cytotoxicity compared to 70%, 60% and 
31% cytotoxicity produced by control cultures re- 
spectively at 50:1, 25:1 and 10:1 E:T cell ratios. Se at 
1/2g/ml produced very significant suppression ofcy-  
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Fig.  2. N K  Act iv i ty  o f  l y m p h o c y t e s  p r e i n c u b a t e d  wi th  Se. 1 x 
106 PBL/ml were incubated with varying concentrations of Se 
for 48 h at 37°C, washed and tested for NK activity against 
prelabeled K562 target cells at varying E:T cell ratios. Values 
represent mean % cytotoxicity t SDM of a single experiment 
performed in triplicate. Three other experiments produced simi- 
lar results. 
Experiments were undertaken to investigate 
whether Se directly affects the activity and gener- 
ation of LAK cells. Direct addition of Se at concen- 
trations ranging from 0.2 to 1.0/2g/ml to a mixture 
of effector and target cells did not affect the lyric 
activity of LAK cells during a 4 h assay period (data 
not presented). Fig. 3 shows the cytotoxic activity 
of  LAK cells generated for 96 h in the presence of  
different concentrations of  Se against NK-nonsensi- 
tire SB target cells. Se at 0.8/~g/ml significantly in- 
hibited LAK cell induction, yielding cytotoxicities 
of 65% (p < 0.01), 45% (p < 0.03) and 8% (p < 
0.03) compared to 86%, 67% and 17% cytotoxic- 
ities manifested by control cultures respectively at 
10:1, 5:1 and 1:1 E:T cell ratios. Se at l gg/ml dem- 
onstrated 66% (p < 0.01), 38% (p < 0.03) and 8% 
(p < 0.03) cytotoxicity versus cytotoxicities of  
86%, 67% and 17% produced by control cultures 
at 10:1, 5:1 and l:1 E:T cell ratios respectively. 
Effect of Se on lymphocyte proliferative responses to 
mitogens 
Previous work by others suggested that Se deficien- 
cy impairs lymphocyte proliferative responses to 
various mitogens (Eskew et al., 1985; Parnharn et 
al., 1983; Shefl'y et al., 1979) and polyclonal B cell 
activation (Chandra et al., 1982). Thus we investi- 
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Fig. 3. Effect o f  Se on  L A K  cell func t ions .  1 x 10 ~' P B L  were 
cultured in IL2-containing medium together with varying con- 
centrations of Se for 96 h, washed and tested for cytotoxic activ- 
ity against NK-resistant SB target cells• Values represent mean 
% cytotoxicity ± SDM of a single experiment performed in 
triplicate• Four other experiments produced similar results• 
181 
erative responses to the T cell mitogens, PHA and 
Con A. Data presented in Fig. 4 demonstrate that 
PHA at 5 and 2.5 #g/ml produced significant prolif- 
erative responses (104,176 cpm and 70,048 cpm re- 
spectively) which were significantly suppressed by 
Se in a dose-dependent manner. At a concentration 
of 0.6/ag/ml, Se yielded reduced counts of 37,527 
cpm (p < 0.01) and 10,481 cpm (p < 0.004) respec- 
tively at 5.0 and 2.5/~g/ml of PHA. At 0.8 ~g Se/ml 
counts were further reduced to 23,353 cpm (p < 
0.001) and 6,606 cpm (p < 0.007) at 5.0 and 2.5 
#g/ml of PHA respectively. A Se concentration of 
1.0/ag/ml virtually completely inhibited PHA stim- 
ulated mitogenesis. 
As shown in Fig. 5, Se produced a similar dose- 
dependent inhibition of Con A-induced prolifera- 
tion. Suppression of responses to 5.0/~g/ml of Con 
A was significant at Se concentrations of 0.6 (p < 
0.001), 0.8 (p < 0.006) and 1 (p < 0.007)/~g/ml. 
D i s c u s s i o n  
NK and LAK cells are involved in host defense 
against tumors and virus infections and in the regu- 
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Fig. 4. Effect of Se on lymphocyte proliferative responses to 
PHA. PBMC (2 x 105) from healthy individuals were cultured 
with either PHA or PHA + different concentrations of Se for 72 
h. [3H]Thymidine (1 /tCi) was added to each well during the last 
24 h of  culture and cells were harvested on glass-fiber filters. 
Radioactivity was measured in a liquid scintillation counter and 
expressed as cpm per 2 x l0 s PBMC. Results are expressed as 
the mean cpm -4- SEM of triplicate values from one representa- 
tive experiment. Three other experiments produced similar re- 
sults. 
lation of several lymphocyte activities (Herberman 
et al., 1978; Rosenberg et al., 1986; Whong-Peng et 
al., 1978; Nair et al., 1981, 1988). Numerous epide- 
miological and experimental investigations suggest 
that Se has an anticarcinogenic effect (Schrauzer et 
al., 1977; Reddy et al., 1988; Uark 1985; Kobayashi 
et al., 1986; Willett et al., 1983; Thomson et al., 
1984). By contrast, it has also been shown that rats 
fed Se (4 ppm) during the post-initiation phase of 
carcinogenesis demonstrated enhanced develop- 
ment of colon cancer (Jacobs et al., 1981). Reddy et 
al. (1988) observed an increased incidence of small 
intestinal tumors induced by carcinogen in rats fed 
an excess of Se, but Se deficiency inhibited colon 
tumorigenesis. Various investigators have noted 
that Se deficiency can result in impaired mitogenic 
responses of lymphocytes (Eskew et al., 1985; Shef- 
fy et al., 1979), decreased numbers and function of 
neutrophils and macrophages (Urban et al., 1986; 
Gyang et al., 1984; Boyne et al., 1979; Serfass et al., 
1976; Talcott et al., 1984; Willett et al., 1988; Old- 
field 1987), and diminished antibody-producing 
cells (Chandra et al., 1982). Talcott et al. (1984) re- 
ported that NK activity was stimulated slightly in 
female Sprague-Dawley rats given 2 ppm of Se. Ip 
and Ip (1981) found no alterations of in vitro im- 
mune functions such as mitogen stimulation or nat- 
ural killer cell activities of lymphocytes from rats 
fed supra-nutritional levels of Se. Koller et al. 
(1986) showed that Se administered to rats in lower 
doses (0.5 2.0 ppm) significantly enhanced splenic 
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Fig. 5. Efl'ect of Se on Con A-induced lymphocyte proliferative 
response. 2 x 105 PBMC were cultured with Con A as described 
in the legend for Fig. 4. 
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NK activity, while no change was observed at high- 
er concentrations of  Se. Further, rats fed lower as 
well as higher Se levels manifested suppressed de- 
layed hypersensitivity responses, while antibody 
synthesis was inhibited only at the highest Se levels. 
This suggests that Se can exert both stimulatory and 
inhibitory effects at various concentrations. Thus 
this dichotomy of effects of  Se on various immune 
responses and tumorigenesis is not clearly under- 
stood and has been the subject of various reviews 
(Willett et al., 1988; Oldfield 1987). The immuno- 
logical alterations observed in these studies may be 
due to selective depletion or homing of certain lym- 
phocyte subpopulations to various lymphoid 
organs depending upon Se deficiency or excess. Al- 
ternatively Se may directly affect lymphocyte func- 
tions or modulate them by selective activation or 
inhibition of various immunoregulatory cell sub- 
populations. Current investigations may resolve 
these questions. 
Se levels in various tissues vary considerably, 
with hair having the highest levels. A blood level of 
3.2 #g/ml and a urine level of  2.68/~g/ml have been 
noted in chronic selenosis (Levander, 1985). We re- 
port herein that Se, at lower concentrations than 
reported in selenosis (e.g. 0.5 1 #g/ml), significantly 
suppresses N K  and LAK cell activities and the pro- 
liferative responses of  normal lymphocytes. The re- 
duced N K  and LAK cell activities observed in Se- 
supplemented media were not due to direct toxicity 
of  effector cells, because lymphocytes cultured in 
Se-supplemented media showed viability similar to 
control cultures without added Se. Further, equal 
numbers of  viable effector cells were consistently 
used for control and Se-supplemented cultures for 
all assays. Experiments were also undertaken to ex- 
amine whether inhibition of cytotoxicity was due to 
increased resistance of target cells to lysis after 
treatment with Se. Target cells were labeled with 
51Cr, preincubated with Se, washed and used in NK 
cell assays. The results demonstrated that preincu- 
bation of targets with Se did not affect their sensi- 
tivity to lysis by effector cells (data not presented). 
In assays where effector cells were precultured in 
Se-containing medium, Se was removed after wash- 
ing and the washed effector cells were then mixed 
with target cells, thus minimizing the carryover of  
Se to the mixture. These studies suggest that the 
effect of  Se appears to be directly or indirectly on 
effector cells and not on target cells. 
The exact mechanisms by which NK or LAK cell 
functions are affected in vitro by excess Se are not 
understood. Several explanations may underlie this 
suppression, including: (1) induction of cells capa- 
ble of inhibiting N K / L A K  cell functions; (2) de- 
creased ability to recruit N K / L A K  cells from pre- 
cursors; (3) reduced production of N K / L A K -  
cell-stimulating lymphokines (e.g., interferon/inter- 
leukin 2); (4) decreased production of cytotoxic fac- 
tor; (5) failure of  helper cell activation; (6) blocking 
of N K / L A K  cell receptors, thus minimizing target 
binding; and/or (7) altered levels of reactive oxygen 
metabolites such as hydrogen peroxide, hydroxyl 
radical, or other oxygen intermediates which are be- 
lieved to be involved in mediating cytotoxic reac- 
tions (Nathan, 1982). These possibilities remain to 
be investigated. Thus, excess levels of  Se as reported 
herein interfere with the cytotoxic functions of  NK 
and LAK cells. To achieve an effective anti tumor 
response in adoptive immunotherapy against malig- 
nancy, using IL2 or LAK cells, special consider- 
ation should be given to the blood Se levels of these 
patients. 
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